MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-PY-03-0001868
Solistaa Pharmaceuticals Private Limited - food and beverages in Puducherry, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹57.79 Cr
▲ 8% YoY
Net profit · FY 2025
₹37.45 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹7.49 Cr
EBITDA margin 13%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹4.15 Cr
Issued & subscribed
Open charges
₹31.56 Cr
Satisfied ₹33.75 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
149
Provident fund records
About Solistaa Pharmaceuticals Private Limited
Data last updated:
Solistaa Pharmaceuticals Private Limited is a private limited company based in Puducherry, India. It operates in the organic and health foods segment of the food and beverages sector. It was incorporated on 27 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24304PY2017PTC008222. Its GSTIN is 34AAZCS5166M1ZE (Puducherry). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.15 Cr. It is led by directors including Paramasivan Sivarajakumar and Kandoth Kunnumpreth Vinupal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.37 1st Cross Perumal Raja Garden Reddiarpalayam, Puducherry, India – 605010.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.79 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹37.45 Lakh (net margin 0.6%) and EBITDA of ₹7.49 Cr (EBITDA margin 13%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 26% over five years.
The company has about 149 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Solistaa. As per MCA filings, the company has open charges of ₹31.56 Cr and satisfied charges of ₹33.75 Cr on record. Court records list 7 cases involving the company, including 7 filed against it; 1 case is pending. The company has 5 deals on record (2 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.25 Cr; the latest was in November 2023. Its 3 peer companies in the Food and Beverages industry (Health and Organic Foods, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Vaasavaa Pharmaceuticals Private Limited with revenue of ₹59.28 Cr.
Solistaa Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0001868). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solistaa.in.
Company details
CIN U24304PY2017PTC008222
Registration Number 008222
Incorporation Date 27 November 2017
ROC Pondicherry
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PY-03-0001868
Key People
Paramasivan Sivarajakumar Director Kandoth Kunnumpreth Vinupal Director Sundararajalu Director Recognitions & Rankings of Solistaa Pharmaceuticals
Contact details
Solistaa Pharmaceuticals Private Limited's registered office is in Puducherry, Puducherry. Its website is solistaa.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.37 1st Cross Perumal Raja Garden Reddiarpalayam, Puducherry, India – 605010
- IndustryFood and Beverages, Organic & Health Foods
To see the full contact details of Solistaa Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Solistaa Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Solistaa Pharmaceuticals operates one associated brand: Solistaa. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nutraceutical manufacturing and pharmaceutical formulation development in India. | solistaa.in |
Business activity
The main business activities of Solistaa Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Solistaa Pharmaceuticals Private Limited, buy the company report.
Financials of Solistaa Pharmaceuticals Private Limited
FY 2024 filings availableSolistaa Pharmaceuticals Private Limited reported revenue of ₹57.79 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹57.79 Cr ▲ 8%
Net profit · FY 2025
₹37.45 Lakh margin 0.6%
EBITDA · FY 2025
₹7.49 Cr margin 13%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 8%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 23%
5 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 8% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Solistaa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Solistaa Pharmaceuticals Private Limited
Solistaa Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paramasivan Sivarajakumar | Director | 27 Nov 2017 | 8 Years 11 Months | Current |
| Kandoth Kunnumpreth Vinupal Also directs: Solqpharm Solutions Private Limited | Director | 27 Nov 2017 | 8 Years 11 Months | Current |
| Sundararajalu | Director | 30 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Solistaa Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Food and Beverages industry (Health and Organic Foods, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vaasavaa Pharmaceuticals Private Limited | ₹59.28 Cr (FY 2025) | 16.0% | Solapur, Maharashtra, India | |||
| Solistaa Pharmaceuticals Private Limitedthis company | ₹57.79 Cr (FY 2025) | ₹37.45 Lakh | 0.6% | 8.0% | 149 | Puducherry, India |
| Stedman Pharmaceuticals Private Limited | ₹57.77 Cr (FY 2024) | 9.0% | Chennai, Tamil Nadu, India | |||
| Accretion Pharmaceuticals Limited | ₹57.47 Cr (FY 2025) | 329.0% | Sanand, Gujarat, India |
To see the full peer comparison of Solistaa Pharmaceuticals Private Limited, buy the company report.
Auditor
Solistaa Pharmaceuticals Private Limited is audited by REITA SONAL AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| REITA SONAL AND ASSOCIATES | FY 2024 | 014094S |
Shareholding
The shareholding of Solistaa Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Solistaa Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹31.56 Cr
Satisfied charges
₹33.75 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2024 | 100999168 | Sidbi | ₹2.6 Cr | Open | |
| 15 Apr 2024 | 100913690 | State Bank of India | ₹18.75 Cr | Open | |
| 26 Mar 2024 | 100887277 | Sidbi | ₹1.65 Cr | Open | |
| 21 Jul 2023 | 100749354 | Sidbi | ₹1.2 Cr | Open | |
| 30 Aug 2022 | 100604564 | Sidbi | ₹1 Cr | Open |
To see the full charge records of Solistaa Pharmaceuticals Private Limited, buy the company report.
Total charge records: 19 View all charges
Deals & funding
Solistaa Pharmaceuticals Private Limited has 5 deals on record (2 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.25 Cr; the latest was in November 2023.
Total deals
5
Secondary share transfers
2
Funding rounds
2
Rights issue
1
Disclosed funding
₹4.25 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | Funding round · Series B | ₹1.29 Cr | Investors: Amapharm GmBH |
| Sep 2023 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Sep 2019 | Funding round · Series A | ₹2.96 Cr | Investors: Amapharm GmBH |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jul 2018 | Rights issue | ₹2.7 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Solistaa Pharmaceuticals Private Limited has 7 court cases on record: 7 filed against it. 1 case is pending and 6 are disposed.
Total cases
7
Filed against the company
7
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Sanzyme Biologics Pvt Ltd, Rep. by Ms. Ayushi Pradhan | Disposed |
| District court, Erode, Tamil Nadu | Criminal case | Filed against the company by Rci Specialities Pvt Ltd, Rep by Its Manager,S.D.Ramasubramanian | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Wang Pharmaceuticals and Chemicals | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Sanzyme Biological Private Limited, Rep. by Ms. Ayushi Pradhan | Disposed |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Sanzyme Biologicals Private Limited, Rep. by Ms. Ayushi Pradhan | Disposed |
To see the full case history of Solistaa Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solistaa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Solistaa Pharmaceuticals Private Limited has a workforce of 149 employees on its EPFO records as of Feb 2026, across 1 active EPFO establishment.
Employee count
149
Active EPFO establishments
1
Employee growth
29.6%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 149 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Solistaa Pharmaceuticals Private Limited, buy the company report.
GST
Solistaa Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AAZCS5166M1ZE | Puducherry | Active | 26 Dec 2017 |
| 33AAZCS5166M1ZG | Tamil Nadu | Active | 08 Jun 2018 |
To see the full GST registrations and return filing status of Solistaa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Solistaa Pharmaceuticals Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Mangalaraj Kirubakaran Daniel ceased to be Director on 17 Mar 2022.
Charges
A charge with Sidbi amounted to Rs. 2.60 Cr with Charge ID 100999168 was registered on 13 Nov 2024.
AGM
Solistaa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 20 Mar 2020 via Charge ID 100331721 with Sidbi was fully satisfied on 07 Jun 2024.
Charges
A charge registered on 02 Dec 2022 via Charge ID 100668721 with Others was fully satisfied on 27 May 2024.
Charges
A charge registered on 30 Nov 2022 via Charge ID 100668650 with Others was fully satisfied on 27 May 2024.
Charges
A charge registered on 19 Nov 2022 via Charge ID 100669046 with Others was fully satisfied on 27 May 2024.
Charges
A charge with State Bank Of India amounted to Rs. 18.75 Cr with Charge ID 100913690 was registered on 15 Apr 2024.
Filing
Solistaa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pondicherry.
Charges
A charge with Sidbi amounted to Rs. 1.65 Cr with Charge ID 100887277 was registered on 26 Mar 2024.
Charges
A charge with Sidbi amounted to Rs. 1.20 Cr with Charge ID 100749354 was registered on 21 Jul 2023.
Charges
A charge with Others of Rs. 15.00 Cr registered on 19 Nov 2022 with Charge ID 100669046 was modified on 24 Jun 2023.
Charges
A charge with Others of Rs. 1.10 Cr registered on 02 Dec 2022 with Charge ID 100668721 was modified on 21 Feb 2023.
31 earlier events are in the company report.
Frequently asked questions
Solistaa Pharmaceuticals is an active private limited company based in Puducherry, India. The company works in organic and health foods, within the food and beverages industry. It was incorporated on 27 November 2017 (9+ years old) and is registered under CIN U24304PY2017PTC008222.
Solistaa Pharmaceuticals has 3 current directors:
- Paramasivan Sivarajakumar - Director
- Kandoth Kunnumpreth Vinupal - Director
- Sundararajalu - Director
The latest financial statements of Solistaa Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Solistaa Pharmaceuticals is 34AAZCS5166M1ZE, registered in Puducherry. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AAZCS5166M1ZG (Tamil Nadu).
The CIN (Corporate Identification Number) of Solistaa Pharmaceuticals is U24304PY2017PTC008222. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solistaa Pharmaceuticals has 7 court cases on record: 7 filed against it. 1 is pending.
Solistaa Pharmaceuticals was incorporated on 27 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pondicherry.
Solistaa Pharmaceuticals has 5 deals on record (2 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.25 Cr; the latest was in November 2023.
The peers of Solistaa Pharmaceuticals by revenue are Vaasavaa Pharmaceuticals Private Limited, Stedman Pharmaceuticals Private Limited, Accretion Pharmaceuticals Limited, all in the Food and Beverages industry (Health and Organic Foods, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mangalaraj Kirubakaran Daniel ceased to be Director on 17 Mar 2022. Konetampet Gopalakrishnan ceased to be Director on 13 Mar 2018. Sundararajalu was appointed as Director on 30 Jan 2018. Solistaa Pharmaceuticals has 5 board changes on record in total.
Yes, Solistaa Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-PY-03-0001868).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages